Israele - ebraico - Ministry of Health

novartis pharma services ag - everolimus 0.25 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.

Israele - ebraico - Ministry of Health

novartis israel ltd - everolimus - טבליה - everolimus 0.5 mg - everolimus - everolimus - kidney and heart transplantationcertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.

Israele - ebraico - Ministry of Health

novartis israel ltd - everolimus - טבליה - everolimus 0.75 mg - everolimus - everolimus - kidney and heart transplantationcertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.

Israele - ebraico - Ministry of Health

novartis israel ltd - everolimus - טבליה - everolimus 0.25 mg - everolimus - everolimus - kidney and heart transplantationcertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.

Israele - ebraico - Ministry of Health

novartis israel ltd - oxcarbazepine - טבליות מצופות פילם - oxcarbazepine 300 mg - oxcarbazepine - oxcarbazepine - treatment of primary generalised tonic-clonic seizures and partial seizures with or without secondary generalization.

Israele - ebraico - Ministry of Health

novartis israel ltd - oxcarbazepine - טבליות מצופות פילם - oxcarbazepine 600 mg - oxcarbazepine - oxcarbazepine - treatment of primary generalized tonic-clonic seizures and partial seizures with or without secondary generalization.

Israele - ebraico - Ministry of Health

novartis israel ltd - canakinumab - תמיסה להזרקה - canakinumab 150 mg / 1 ml - canakinumab

Israele - ebraico - Ministry of Health

novartis israel ltd - secukinumab - תמיסה להזרקה - secukinumab 150 mg/ml - secukinumab

Israele - ebraico - Ministry of Health

novartis israel ltd - siponimod as fumaric acid - טבליות מצופות פילם - siponimod as fumaric acid 0.25 mg - siponimod

Israele - ebraico - Ministry of Health

novartis israel ltd - siponimod as fumaric acid - טבליות מצופות פילם - siponimod as fumaric acid 2 mg - siponimod